Stéphane Terry is a Molecular and Cellular biologist whose research has been focused on prostate cancer (PCa). He earned his PhD from the University of ParisSud (France) in 2008 for his work on cell signaling perturbations in PCa cells following androgen ablation. After a post-doctoral training at the Weill Cornell Medical College on molecular characterization of PCa, he returned to France where he is currently a young investigator working closely with clinicians at the Institut Mondor de Recherche Biomedicale. His current interest is in identifying mechanisms by which PCa cells acquire neuroendocrine characteristics as a means to adapt and progress through treatments. Stéphane Terry is a Molecular and Cellular biologist whose research has been focused on prostate cancer (PCa). He earned his PhD from the University of ParisSud (France) in 2008 for his work on cell signaling perturbations in PCa cells following androgen ablation. After a post-doctoral training at the Weill Cornell Medical College on molecular characterization of PCa, he returned to France where he is currently a young investigator working closely with clinicians at the Institut Mondor de Recherche Biomedicale. His current interest is in identifying mechanisms by which PCa cells acquire neuroendocrine characteristics as a means to adapt and progress through treatments.

identifying mechanisms by which PCa cells acquire neuroendocrine characteristics as a means to adapt and progress through treatments.